WO1990014441A1 - Methods for tagging and tracing materials with nucleic acids - Google Patents
Methods for tagging and tracing materials with nucleic acids Download PDFInfo
- Publication number
- WO1990014441A1 WO1990014441A1 PCT/US1990/002709 US9002709W WO9014441A1 WO 1990014441 A1 WO1990014441 A1 WO 1990014441A1 US 9002709 W US9002709 W US 9002709W WO 9014441 A1 WO9014441 A1 WO 9014441A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acid
- taggant
- substance
- nucleic acids
- tagging
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09F—DISPLAYING; ADVERTISING; SIGNS; LABELS OR NAME-PLATES; SEALS
- G09F3/00—Labels, tag tickets, or similar identification or indication means; Seals; Postage or like stamps
-
- C—CHEMISTRY; METALLURGY
- C06—EXPLOSIVES; MATCHES
- C06B—EXPLOSIVES OR THERMIC COMPOSITIONS; MANUFACTURE THEREOF; USE OF SINGLE SUBSTANCES AS EXPLOSIVES
- C06B23/00—Compositions characterised by non-explosive or non-thermic constituents
- C06B23/008—Tagging additives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H21/00—Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties
- D21H21/14—Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties characterised by function or properties in or on the paper
- D21H21/40—Agents facilitating proof of genuineness or preventing fraudulent alteration, e.g. for security paper
- D21H21/44—Latent security elements, i.e. detectable or becoming apparent only by use of special verification or tampering devices or methods
- D21H21/46—Elements suited for chemical verification or impeding chemical tampering, e.g. by use of eradicators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/13—Tracers or tags
Definitions
- the present invention provides methods for tagging and tracing materials using nucleic acids as taggants.
- the process of tagging involves altering a substance in a manner that allows for the subsequent identification of the substance by detecting the alteration.
- the alteration disclosed herein involves nucleic acids.
- Tagging aids in the determination of product identity and so provides information useful to manufacturers and consumers.
- Some of the diverse uses of tagging methods and reagents include the identification of the manufacturer of an explosive, even after detonation, and the determination of flow patterns, so as to measure the spread of pollutants.
- the present invention provides a significant advance in the field, because the taggants can encode substantial amounts of information to aid subsequent identification.
- polypeptide taggants use the order of amino acids in the polypeptide to encode information.
- the present invention provides a method for tagging a material (any substance) by treating the material with a nucleic acid taggant so that said nucleic acid attaches to said material in an amount sufficient for subsequent detection.
- the nucleic acid taggant comprises a specific nucleotide sequence or has a distinct composition of specific nucleotides to facilitate tracing.
- the present invention also provides a method for tracing a material tagged with a nucleic acid taggant that comprises determining the presence of a nucleic acid sequence specific for said taggant in the material.
- the tracing method also comprises treating the material under conditions that would result in the amplification of a nucleic acid sequence of a taggant, if present, to determine if the specific nucleic acid sequence is present.
- this invention provides for a method of monitoring the presence of a substance which comprises tagging the substance with a nucleic acid, collecting said substance and detecting said nucleic acid.
- An additional step of amplification of the nucleic acid is also described herein. This amplification is typically done prior to detection and is preferably achieved using polymerase chain reaction technology.
- the nucleic acids can be either naturally occurring or synthetically derived. Preferred synthetic nucleic acids are comprised of inosine bases or 7-deazo-2'-deoxyguanosine nucleotides.
- the materials or substances of this invention include those selected from the group consisting of air pollutants, oils, aromatic compounds, explosive compositions, food stuffs, medicaments, inks, paper goods, and paint products.
- the nucleic acids can be optionally bound to a component of the tagged substance through a covalent bond. "Covalently bound to a component of the substance,” means that the nucleic acids are covalently bound to the tagged material or component thereof. Where the material is comprised of different components such as different chemical compounds, the nucleic acid may be covalently bound to any one or all of the components.
- the nucleic acids used as taggants may be free or they may be covalently bound to a solid support (such as latex beads, dextran or magnetic beads) which is then mixed with the material being tagged.
- nucleic acids may be encapsulated by polymeric substances (such as proteins) or by lipophilic compositions (such as liposomes).
- polymeric substances such as proteins
- lipophilic compositions such as liposomes.
- This invention also provides methods for tagging substances wherein the method comprises the step of incorporating a nucleic acid onto the substance or into the substance.
- the preferred taggants and substances are as described above.
- compositions of tagged substances where the taggant is a nucleic acid having a specific sequence of nucleotide bases for retrospective identification.
- Preferred compositions are those which comprise the nucleic acid and a substance selected from the group consisting of air pollutants, oils, aromatic compounds, explosive compositions, food stuffs, medicaments, inks, paper goods, and paint products.
- the nucleic acids can be synthetically derived, covalently bound to solid support, or encapsulated, as described above.
- kits for the detection of substances tagged with nucleic acids can include nucleic acids for the detection of the taggants, for the amplification of the taggants and for use as taggants.
- SUBSTANCE - a material that can be tagged and traced according to the method of the invention.
- NUCLEIC ACID a deoxyribonucleotide or ribonucleotide polymer in either single- or double-stranded form; modified nucleotides may comprise all or part of the nucleic acid.
- TAGGANT a nucleic acid that comprises a specific nucleotide sequence or has a specific nucleotide composition, the specificity of said sequence or composition providing a means to store information.
- Taggants are typically non-biologically functioning in that they are not a part of a functional nucleic acid sequence operating in a living cell. Those of skill will recognize that living organisms contain unique nucleic acid sequences either natural or artificially introduced, this invention is not meant to embrace these naturally occurring and biologically functional forms of taggants.
- Taggants are generally added to substances. They are not a functioning part of the substance.
- TAGGING the process of treating a material with a composition, the taggant, for subsequent identification of the material by detection of the taggant.
- TRACING the process of determining the origin or source of a material.
- This invention relates to the use of nucleic acids for monitoring, detecting and tracing substances released into the environment or released into the stream of commerce.
- the nucleic acids are used as an additive to tag such substances.
- the specifics of compounding the nucleic acid as a taggant and its subsequent recovery for analysis is dependent upon the specific substance into which the nucleic acid is being added. The following guidelines are offered.
- the nucleic acids for use in this invention can provide a limitless amount of information.
- combinations of universal sequences accepted as industrial standards
- by varying levels of specific sequences one can identify the type of generic product, the product's origin (company specific sequences), the lot or batch, and even provide an identifier for a unit of commerce.
- nucleic acids suitable for use in this invention include both natural and non-natural nucleic acids. They can be single or double stranded. Natural nucleic acids refer to polymers of either DNA or RNA including the 5 naturally occurring bases, adenine, thymine, guanine, cytosine and uracil.
- Non-natural or synthetic nucleic acids can also be used in this invention.
- Synthetic nucleic acids in some instances have advantages over natural nucleic acids, e.g. in stability, solubility, etc. Some synthetic nucleotides are less likely to be degraded by nuclease activity, by chemically active substances or by environmental conditions such as heat or ultraviolet radiation. The use of non-natural nucleotides is limited only by their ability to be effectively detected by the selected detection means. For tagging methods using the preferred PCR technology, the synthetic nucleic acid must form duplexes with the primers and function as a template for the polymerases used in the procedure.
- Non-natural nucleic acids for use in this invention include those incorporating inosine bases, and derivatized nucleotides, such as 7-deazo-2'deoxyguanosine, methyl- (or longer alkyl-) phosphonate oligodeoxy- nucleotides, phosphorothioate oligodeoxynucleotides, and alpha-anomeric oligodeoxynucleotides.
- the nucleic acids for use in this invention can provide a limitless amount of information. By using combinations of universal sequences (accepted as industrial standards) and by varying levels of specific sequences, one can identify or authenticate the type of generic product, the product's origin (company specific sequences) and the lot or batch.
- the substances can be either inert or active, with liquids and aerosols being further divided as being either polar or non-polar.
- Inert solids such as paper, many pharmaceutical products, wood, some foodstuffs, or polymer compounds (e.g., plastics), can be processed with the taggant or the taggant can be sprayed onto the surface of the solid.
- Taggants can be physically mixed with inert liquids or gases.
- Chemically active substances such as foodstuffs with enzymatic activity, polymers with charged groups, or acidic pharmaceuticals may require that a protective composition be added to the nucleic acid taggants.
- Protective compositions would include substances which would encapsulate the nucleic acids and protect them from enzymatic or chemical degradation.
- Liposomes are a technology presently available for use as a protective capsule for nucleic acids. Typical liposomes are micelle bodies formed by detergents.
- polymeric substances can be used to electrostatically bind to and encapsulate the nucleic acids.
- Polymeric substances would include proteins such as virus coat proteins.
- the protective composition for a liquid is preferably compatible with the liquid's polarity.
- the compatibility of taggant with a liquid substance is preferred for both inert and chemically active liquids.
- oils and other non-polar liquids can be tagged effectively by the use of detergents added to the taggant prior to the addition of the taggant to the liquid.
- the taggants are simply mixed with the gas. This is because the taggant is much smaller that what is usually considered to be dust (0.2 microns) particles. Containerized gases would have the taggants placed in the container.
- the taggants could be mixed before release or at the time of release.
- an aerosol delivery device to an exhaust outlet and introduce a metered amount of taggant as the gas is released.
- nucleic acid taggants for the tracing of radioactive products, including waste, is anticipated.
- the means for tracing would be as described herein for non-radioactive materials with the use of appropriate protection. It should be noted that short oligonucleotides of less than 1000 bases are preferred due to their greater stability against degradation from radiation.
- the amount to add to a substance and preferred means for recovery and detection of nucleic acid taggant is dependent upon the substance being monitored.
- the means for detection and the amount of available sample being collected will dictate the amount of taggant required for each application of this invention. Therefore, in the absence of a means to amplify the taggant, the amount of taggant added would depend on the logistics of collecting enough substance to recover a detectable amount of taggant.
- the preferred molecular structure of the nucleic acid taggant will vary with the means used to detect the nucleic acid. Typically at least 20 bases are necessary to ensure adequate specificity for any taggant so that accidental contamination will not lead to false results.
- the sequence should comprise multiple regions of specificity. The longer the sequence, the more information may be carried.
- the sample is washed or extracted with either distilled water or a buffered solution.
- Physiological pH is preferred as pH extremes may degrade nucleic acid.
- Charged substances might require washing in high molarity salt buffers to act as ion exchangers with the electrostatically bound nucleic acids.
- Detergents either ionic or non-ionic, are helpful to remove nucleic acids from surfaces or from complex biological mixtures. Using phenol based extractions or phenol/chloroform extractions, one can recover nucleic acid from complex biological substances or from oil based substances.
- the recovered nucleic acid can be concentrated by standard techniques such as precipitation with alcohol, evaporation, or microfiltration. Because of the limits of sensitivity for the detection of nucleic acid, there is an obvious advantage to using methods for amplifying the recovered taggant. For example, using the polymerase chain reaction procedure [PCR] disclosed in U.S. Pat. Nos. 4,683,202 and 4,683,195 and European Patent Applications Nos. 258,017 and 237,362, one can amplify and detect nucleic acid molecule. The PCR method can be used with modification to amplify single stranded taggants, double stranded taggants and DNA or RNA taggants.
- PCR polymerase chain reaction procedure
- PCR amplification can be carried out in a variety of ways. For instance, inverse PCR and asymetric PCR are well known variations of the technique.
- promoters for RNA transcription can be incoroporated into primers, which, when extended and replicated by PCR, can then be used to create RNA copies of the target sequence. These RNA copies can, in turn, be several reverse transcribed into DNA, which can then be amplified by PCR. As with all PCR processes, reaction cycles can be repeated as often as desired.
- a double stranded taggant is preferred, although a single stranded taggant becomes a double stranded after the first cycle of amplification.
- the taggant is preferably a minimum of 60 bases long. This permits the hybridization of two primers which are preferably each 20 bases long, and which, when hybridized to the taggant, are separated by an internal region between the primer specific regions of the taggant of about an additional 20 bases.
- prior knowledge of the target sequence is necessary to provide appropriate primers. This necessary knowledge offers a valuable degree of security for those who desire it. For without the primers which can remain proprietary, the taggant can be virtually undetectable.
- nucleic acid hybridization assays For detection of taggants, one can use standard nucleic acid hybridization assays or nucleic acid sequencing.
- the standard nucleic acid hybridization assays include single phase and mixed phase assays such as sandwich assays.
- nucleic acid hybridization assays require prior knowledge of the sequence being detected. Knowledge of the taggant' s sequence permits the use of appropriate complementary oligonucleotides for capture or signal purposes. Alternatively, the nucleic acids recovered from the samples can be sequenced using conventional sequencing technology. Commercially available kits are suitable for this purpose.
- the basic sequencing technology is derived from seminal references such as the Maxam and Gilbert procedure for DNA sequencing described in Methods in Enzymology 65: (part 1) 497-559. Sequencing is a more difficult procedure to conduct, but offers greater reliability than nucleic acid hybridization assays. This is due to the possibility of contamination by extraneous nucleic acid with sufficient complementarity to hybridize to the selected probes and offer false positives. Kits.
- kits designed to tag and monitor substances.
- a kit designed to tag and monitor substances.
- a kit would include nucleic acid taggants and polynucleotides which are complementary to the taggants.
- the complementary polynucleotides could be designed for use as signal probes, capture probes or as primers in the PCR method.
- the kits might also contain signal means such as enzymes, radio-isotopes, fluorescent labels and the like.
- the following examples all used a double stranded taggant of a sequence complementary to the DQ ⁇ allele 1.3.
- This sequence is derived from a rare DQ ⁇ type and has a reduced likelihood of being accidently present as a contaminant in the materials described below.
- the taggant was also labelled with 32 P to follow experimentally the tag during the entire procedure. The unique sequence of one strand of this taggant has been provided in Table 1.
- the taggant was recovered as described below. All amplifications were done with 40 cycles on a Perkins-Elmer Cetus Instruments thermal cycler using the protocols and reagents provided by the manufacturer. Biotinylated primers GH26 and GH27 having the sequence provided in Table 1 were used to initiate the PCR process.
- the basic PCR mixture consists of: lOx TAQ buffer 10 ⁇ l lOOmM Tris HC1 pH 8.3
- Each cycle consists of 30 second incubations at 94°C followed by 30 sec at 55°C and 30 sec at 72°C. After the final (fortieth) cycle, the sample mixture is incubated at 72°C for ten minutes.
- Detection of the PCR amplified taggant is achieved by standard nucleic acid hybridization assays using the capture probe provided in Table 1.
- the protocol for the hybridization assay is not critical. The means used have been detailed in PCT Publication No. 89/11548, published November 30, 1989, which is hereby incorporated by reference. Briefly, the taggant was captured by hybridization to an immobilized probe, GH89 (table 1). The probe was immobilized using ultraviolet irradiation on a positively charged nylon membrane.
- Preparation (a) Add long of taggant to 1 ml of distilled water, (b) mix solution with 1 g of nitrocellulose based gunpowder, and (c) dry in air or under vacuum a 85°C. Recovery: (a) Wash gunpowder with distilled water (1 ml); (b) add 50 ⁇ l of this solution to PCR reaction mix or place gunpowder flakes directly in 100 ⁇ l PCR reaction mix; and (c) amplify.
- Preparation (a) Add 48 ⁇ g of taggant to 325 ⁇ l of distilled water; (b) add 50 ⁇ l of this mix to a tablet; and (c) allow to dry. Recovery: (a) dissolve the tablet in 5 ml of H 2 0; (b) place 50 ⁇ l of this solution in PCR mix; and (c) amplify.
- Preparation Add 20 ng taggant to each gram of food by physical mixing or spray application.
Abstract
Methods for tagging and tracing materials using nucleic acids as taggants allow for the identification of diverse materials. The process of tagging involves altering a substance in a manner that allows for the subsequent identification of the substance by detecting the alteration. The alteration disclosed herein involves nucleic acids. The methods are especially useful when the nucleic acid taggant is amplified prior to the identification step.
Description
METHODS FOR TAGGING AND TRACING MATERIALS WITH NUCLEIC ACIDS
The present invention provides methods for tagging and tracing materials using nucleic acids as taggants. The process of tagging involves altering a substance in a manner that allows for the subsequent identification of the substance by detecting the alteration. The alteration disclosed herein involves nucleic acids.
Society currently attempts to track the manufacture and distribution of a large number of diverse substances, including (1) natural resources such as animals, plants, oil, minerals, and water; (2) chemicals such as drugs, solvents, petroleum products, and explosives; (3) commercial by-products including pollutants such as radioactive or other hazardous waste; and (4) articles of manufacture such as guns, typewriters, automobiles and automobile parts. Tagging aids in the determination of product identity and so provides information useful to manufacturers and consumers. Some of the diverse uses of tagging methods and reagents include the identification of the manufacturer of an explosive, even after detonation, and the determination of flow patterns, so as to measure the spread of pollutants. The present invention provides a significant advance in the field, because the taggants can encode substantial amounts of information to aid subsequent identification. Moreover, by using recently available amplification technology, one can detect far less taggant than ever before. In fact, the present tagging methods work with such vanishingly small levels of taggant that drugs tagged by the present method can still pass the FDA standards (10 pg/dose) for amount of DNA, in this case, taggant DNA, in any product. The use of tagging substances with polypeptides is known. U.S. Patent Nos.
4,359,353 and 4,441,943. As with the nucleic acid taggants of the subject invention, the polypeptide taggants use the order of amino acids in the polypeptide to encode information.
The present invention provides a method for tagging a material (any substance) by treating the material with a nucleic acid taggant so that said nucleic acid attaches to said material in an amount sufficient for subsequent detection. The
nucleic acid taggant comprises a specific nucleotide sequence or has a distinct composition of specific nucleotides to facilitate tracing. The present invention also provides a method for tracing a material tagged with a nucleic acid taggant that comprises determining the presence of a nucleic acid sequence specific for said taggant in the material. In a preferred embodiment, the tracing method also comprises treating the material under conditions that would result in the amplification of a nucleic acid sequence of a taggant, if present, to determine if the specific nucleic acid sequence is present.
More particularly, this invention provides for a method of monitoring the presence of a substance which comprises tagging the substance with a nucleic acid, collecting said substance and detecting said nucleic acid. An additional step of amplification of the nucleic acid is also described herein. This amplification is typically done prior to detection and is preferably achieved using polymerase chain reaction technology. The nucleic acids can be either naturally occurring or synthetically derived. Preferred synthetic nucleic acids are comprised of inosine bases or 7-deazo-2'-deoxyguanosine nucleotides.
The materials or substances of this invention include those selected from the group consisting of air pollutants, oils, aromatic compounds, explosive compositions, food stuffs, medicaments, inks, paper goods, and paint products. The nucleic acids can be optionally bound to a component of the tagged substance through a covalent bond. "Covalently bound to a component of the substance," means that the nucleic acids are covalently bound to the tagged material or component thereof. Where the material is comprised of different components such as different chemical compounds, the nucleic acid may be covalently bound to any one or all of the components. The nucleic acids used as taggants may be free or they may be covalently bound to a solid support (such as latex beads, dextran or magnetic beads) which is then mixed with the material being tagged. Alternatively the nucleic acids may be encapsulated by polymeric substances (such as proteins) or by lipophilic compositions (such as liposomes).
This invention also provides methods for tagging substances wherein the method comprises the step of incorporating a nucleic acid onto the substance or into the substance. The preferred taggants and substances are as described above.
This invention also provides compositions of tagged substances where the taggant is a nucleic acid having a specific sequence of nucleotide bases for retrospective identification. Preferred compositions are those which comprise the nucleic acid and a substance selected from the group consisting of air pollutants, oils, aromatic compounds, explosive compositions, food stuffs, medicaments, inks, paper goods, and paint products. The nucleic acids can be synthetically derived, covalently bound to solid support, or encapsulated, as described above.
This invention also provides for kits for the detection of substances tagged with nucleic acids. Such kits can include nucleic acids for the detection of the taggants, for the amplification of the taggants and for use as taggants.
The following definitions are provided to aid understanding of the invention: SUBSTANCE - a material that can be tagged and traced according to the method of the invention.
NUCLEIC ACID - a deoxyribonucleotide or ribonucleotide polymer in either single- or double-stranded form; modified nucleotides may comprise all or part of the nucleic acid. TAGGANT - a nucleic acid that comprises a specific nucleotide sequence or has a specific nucleotide composition, the specificity of said sequence or composition providing a means to store information. Taggants are typically non-biologically functioning in that they are not a part of a functional nucleic acid sequence operating in a living cell. Those of skill will recognize that living organisms contain unique nucleic acid sequences either natural or artificially introduced, this invention is not meant to embrace these naturally occurring and biologically functional forms of taggants. Taggants are generally added to substances. They are not a functioning part of the substance.
TAGGING - the process of treating a material with a composition, the taggant, for subsequent identification of the material by detection of the taggant.
TRACING - the process of determining the origin or source of a material.
This invention relates to the use of nucleic acids for monitoring, detecting and tracing substances released into the environment or released into the stream of commerce. The nucleic acids are used as an additive to tag such substances. The specifics of compounding the nucleic acid as a taggant and its subsequent recovery for analysis is dependent upon the specific substance into which the nucleic acid is being added. The following guidelines are offered.
Nucleic acids.
The nucleic acids for use in this invention can provide a limitless amount of information. By using combinations of universal sequences (accepted as industrial standards) and by varying levels of specific sequences, one can identify the type of generic product, the product's origin (company specific sequences), the lot or batch, and even provide an identifier for a unit of commerce.
The nucleic acids suitable for use in this invention include both natural and non-natural nucleic acids. They can be single or double stranded. Natural nucleic acids refer to polymers of either DNA or RNA including the 5 naturally occurring bases, adenine, thymine, guanine, cytosine and uracil.
Non-natural or synthetic nucleic acids can also be used in this invention. Synthetic nucleic acids in some instances have advantages over natural nucleic acids, e.g. in stability, solubility, etc. Some synthetic nucleotides are less likely to be degraded by nuclease activity, by chemically active substances or by environmental conditions such as heat or ultraviolet radiation. The use of non-natural nucleotides is limited only by their ability to be effectively detected by the selected detection means. For tagging methods using the preferred PCR technology, the synthetic nucleic acid must form duplexes with the primers and function as a template for the polymerases used in the procedure. Non-natural nucleic acids for use in this invention include those incorporating inosine bases, and derivatized nucleotides, such as 7-deazo-2'deoxyguanosine, methyl- (or longer alkyl-) phosphonate oligodeoxy- nucleotides, phosphorothioate oligodeoxynucleotides, and alpha-anomeric oligodeoxynucleotides.
The nucleic acids for use in this invention can provide a limitless amount of information. By using combinations of universal sequences (accepted as industrial standards) and by varying levels of specific sequences, one can identify or authenticate the type of generic product, the product's origin (company specific sequences) and the lot or batch.
Tagged Substances.
The following substances are not meant to be limiting, but will serve to offer those of skill an understanding of the versatility of this invention. For example, it is expected that this invention will find application in explosives (such as plastic explosives and gunpowder), aerosols (such as automobile or industrial pollutants from smoke stacks), organic solvents (such as from dry cleaners, chemical factories, airports, and gas stations), paper goods (such as newsprint, money, and legal documents), inks, perfumes, and pharmaceutical products (such as medicaments). Preparation of the nucleic acids will vary in accordance with the nature of the substance and upon the expected impact of the environment in which the substance is expected to be placed. The substances can be classified as solids, liquids or gases. The substances can be either inert or active, with liquids and aerosols being further divided as being either polar or non-polar. Inert solids such as paper, many pharmaceutical products, wood, some foodstuffs, or polymer compounds (e.g., plastics), can be processed with the taggant or the taggant can be sprayed onto the surface of the solid. Taggants can be physically mixed with inert liquids or gases.
Chemically active substances, such as foodstuffs with enzymatic activity, polymers with charged groups, or acidic pharmaceuticals may require that a protective composition be added to the nucleic acid taggants. Protective compositions would include substances which would encapsulate the nucleic acids and protect them from enzymatic or chemical degradation. Liposomes are a technology presently available for use as a protective capsule for nucleic acids. Typical liposomes are micelle bodies formed by detergents. Alternatively polymeric substances can be used to
electrostatically bind to and encapsulate the nucleic acids. Polymeric substances would include proteins such as virus coat proteins.
The same approach is used for the addition of taggants to chemically active liquids except the protective composition for a liquid is preferably compatible with the liquid's polarity. The compatibility of taggant with a liquid substance is preferred for both inert and chemically active liquids. For example, oils and other non-polar liquids can be tagged effectively by the use of detergents added to the taggant prior to the addition of the taggant to the liquid. One could rely upon Brownian motion to ensure a uniform distribution in the liquid. For gases, the taggants are simply mixed with the gas. This is because the taggant is much smaller that what is usually considered to be dust (0.2 microns) particles. Containerized gases would have the taggants placed in the container. For gases being released into the atmosphere, the taggants could be mixed before release or at the time of release. For example, to track the pattern of dispersal of gases released by industry, one could attach an aerosol delivery device to an exhaust outlet and introduce a metered amount of taggant as the gas is released.
The use of nucleic acid taggants for the tracing of radioactive products, including waste, is anticipated. The means for tracing would be as described herein for non-radioactive materials with the use of appropriate protection. It should be noted that short oligonucleotides of less than 1000 bases are preferred due to their greater stability against degradation from radiation.
Recovery and detection of taggants.
The amount to add to a substance and preferred means for recovery and detection of nucleic acid taggant is dependent upon the substance being monitored.
The means for detection and the amount of available sample being collected will dictate the amount of taggant required for each application of this invention. Therefore, in the absence of a means to amplify the taggant, the amount of taggant added would depend on the logistics of collecting enough substance to recover a detectable amount of taggant.
The preferred molecular structure of the nucleic acid taggant will vary with the means used to detect the nucleic acid. Typically at least 20 bases are necessary to ensure adequate specificity for any taggant so that accidental contamination will not lead to false results. Preferably, the sequence should comprise multiple regions of specificity. The longer the sequence, the more information may be carried.
However, it will be recognized that the higher the information content of the taggant the more likely that degradation will be become a problem. Typically, fragments under 1 kilobase are preferred.
Recovery of the taggant can be achieved by the use of standard techniques. Typically, the sample is washed or extracted with either distilled water or a buffered solution. Physiological pH is preferred as pH extremes may degrade nucleic acid. Charged substances might require washing in high molarity salt buffers to act as ion exchangers with the electrostatically bound nucleic acids. Detergents, either ionic or non-ionic, are helpful to remove nucleic acids from surfaces or from complex biological mixtures. Using phenol based extractions or phenol/chloroform extractions, one can recover nucleic acid from complex biological substances or from oil based substances.
The recovered nucleic acid can be concentrated by standard techniques such as precipitation with alcohol, evaporation, or microfiltration. Because of the limits of sensitivity for the detection of nucleic acid, there is an obvious advantage to using methods for amplifying the recovered taggant. For example, using the polymerase chain reaction procedure [PCR] disclosed in U.S. Pat. Nos. 4,683,202 and 4,683,195 and European Patent Applications Nos. 258,017 and 237,362, one can amplify and detect nucleic acid molecule. The PCR method can be used with modification to amplify single stranded taggants, double stranded taggants and DNA or RNA taggants.
Those of skill in the art recognize that the PCR amplification can be carried out in a variety of ways. For instance, inverse PCR and asymetric PCR are well known variations of the technique. In another variation, promoters for RNA transcription can be incoroporated into primers, which, when extended and replicated by PCR, can then be used to create RNA copies of the target sequence. These RNA
copies can, in turn, be several reverse transcribed into DNA, which can then be amplified by PCR. As with all PCR processes, reaction cycles can be repeated as often as desired.
For PCR, the preferred means for amplification, a double stranded taggant is preferred, although a single stranded taggant becomes a double stranded after the first cycle of amplification. The taggant is preferably a minimum of 60 bases long. This permits the hybridization of two primers which are preferably each 20 bases long, and which, when hybridized to the taggant, are separated by an internal region between the primer specific regions of the taggant of about an additional 20 bases. When detecting nucleic acid by PCR, prior knowledge of the target sequence is necessary to provide appropriate primers. This necessary knowledge offers a valuable degree of security for those who desire it. For without the primers which can remain proprietary, the taggant can be virtually undetectable.
For detection of taggants, one can use standard nucleic acid hybridization assays or nucleic acid sequencing. The standard nucleic acid hybridization assays include single phase and mixed phase assays such as sandwich assays.
The specific detection procedure used is not critical to this invention. Nucleic acid hybridization technology is not a static art. New developments are anticipated and this invention is applicable to any new improvements. An overview of the state of the art can be found in Nucleic Acid Hybridization A Practical Approach, Eds.
Hames, B.D. and Higgins, S.J., IRL Press, Wash. D.C., 1987.
The use of nucleic acid hybridization assays requires prior knowledge of the sequence being detected. Knowledge of the taggant' s sequence permits the use of appropriate complementary oligonucleotides for capture or signal purposes. Alternatively, the nucleic acids recovered from the samples can be sequenced using conventional sequencing technology. Commercially available kits are suitable for this purpose. The basic sequencing technology is derived from seminal references such as the Maxam and Gilbert procedure for DNA sequencing described in Methods in Enzymology 65: (part 1) 497-559. Sequencing is a more difficult procedure to conduct, but offers greater reliability than nucleic acid hybridization assays. This is due to the possibility of contamination by extraneous nucleic acid with sufficient complementarity to hybridize to the selected probes and offer false positives.
Kits.
This invention also provides for a manufactured product such as a kit designed to tag and monitor substances. Such a kit would include nucleic acid taggants and polynucleotides which are complementary to the taggants. The complementary polynucleotides could be designed for use as signal probes, capture probes or as primers in the PCR method. The kits might also contain signal means such as enzymes, radio-isotopes, fluorescent labels and the like.
All cited references are provided for the convenience of the readers. The knowledge contained therein is well known to those of skill in the art. To the extent that such knowledge may be deemed essential to practice this invention, each of the above-cited references is hereby incorporated by reference.
The following examples are provided for illustrative purposes only and they are not to be interpreted as limitations of the invention.
Examples
The following examples all used a double stranded taggant of a sequence complementary to the DQα allele 1.3. This sequence is derived from a rare DQα type and has a reduced likelihood of being accidently present as a contaminant in the materials described below. The taggant was also labelled with 32P to follow experimentally the tag during the entire procedure. The unique sequence of one strand of this taggant has been provided in Table 1.
The taggant was recovered as described below. All amplifications were done with 40 cycles on a Perkins-Elmer Cetus Instruments thermal cycler using the protocols and reagents provided by the manufacturer. Biotinylated primers GH26 and GH27 having the sequence provided in Table 1 were used to initiate the PCR process.
Table 1. Nucleic acid sequences for DHα, related primers and probes. GH26 - 5' GTGCTGCAGGTGTAAACTTGTACCAG 3' GH27 - 5' CACGGATCCGGTAGCAGCGGTAGAGTTG 3' Taggant sequence DQα -
5' TTTTACGGTCCCTCTGGCCAGTTCACCCATGAATT GATGGAGATGAG CAGTTCTACGTGGACCTGGAGAAGAAGGAGACTGCCTGGCGGTGGCCTGAGT TCAGCAAATTTGGAGGTTTTGACCCGCAGGGTGCACTGAGAAACATGGCTGT GGC AAAACACAACTTGA ACATCATGATTAA ACGCTA 3 ' Capture probe GH89 5' - CTGGAGAAGAAGGAGAC - 3'
The Standard PCR procedure.
The following PCR procedure was used to amplify DQα in each of the different substances illustrated below. The basic PCR mixture consists of: lOx TAQ buffer 10 μl lOOmM Tris HC1 pH 8.3
500mM KC1
15.0mM MgCl2 lOμM GH26 1.5 μl lOμM GH27 1.5 μl lOOmM dNTPs 0.75 μl
5U/μl TAQ 0.5 μl distilled water 35 μl 50μl of the basic PCR mixture is mixed with an equal amount of sample.
Each cycle consists of 30 second incubations at 94°C followed by 30 sec at 55°C and 30 sec at 72°C. After the final (fortieth) cycle, the sample mixture is incubated at 72°C for ten minutes.
Detection of the PCR amplified taggant is achieved by standard nucleic acid hybridization assays using the capture probe provided in Table 1. The protocol for the hybridization assay is not critical. The means used have been detailed in PCT
Publication No. 89/11548, published November 30, 1989, which is hereby incorporated by reference. Briefly, the taggant was captured by hybridization to an immobilized probe, GH89 (table 1). The probe was immobilized using ultraviolet irradiation on a positively charged nylon membrane.
A. Gunpowder
Preparation: (a) Add long of taggant to 1 ml of distilled water, (b) mix solution with 1 g of nitrocellulose based gunpowder, and (c) dry in air or under vacuum a 85°C. Recovery: (a) Wash gunpowder with distilled water (1 ml); (b) add 50 μl of this solution to PCR reaction mix or place gunpowder flakes directly in 100 μl PCR reaction mix; and (c) amplify.
B. Oil Preparation: (a) Mix together 40 μg of taggant, 10 μl "Tween 80" (detergent),
10 μl "Span 80" (detergent), and 100 μl distilled water; and (b) add mixture to 1.7 ml oil. The combination is then thoroughly mixed.
Recovery: Add oil directly to PCR mix, vortex and amplify; or use a standard phenol-chloroform extraction. After treatment with phenol, the taggant was detected in the boundary layer between the oil and water phases.
C. Medicines (water soluble tablets)
Preparation: (a) Add 48 μg of taggant to 325 μl of distilled water; (b) add 50 μl of this mix to a tablet; and (c) allow to dry. Recovery: (a) dissolve the tablet in 5 ml of H20; (b) place 50 μl of this solution in PCR mix; and (c) amplify.
D. Ink
Preparation: If water insoluble, mix with detergents as for tagging oil. If water soluble, add a dilute concentration of taggant directly to the ink. Recovery: As described for oils and medicines.
E. Paper goods
Preparation: (a) Add dilute solution of taggant 2-3 ng/cm2 to paper, and (b) allow to air dry or dry under vacuum.
Recovery: (a) Soak paper in distilled water with or without detergents to aid in solubilization; (b) optionally concentrate taggant; and (c) amplify by standard
PCR procedure.
F. Food Stuffs
Preparation: Add 20 ng taggant to each gram of food by physical mixing or spray application.
Recovery: (a) Food material is washed with distilled water; (b) the rinse is optionally concentrated; and (c) the rinse material is subjected to the standard PCR procedure.
Claims
1. A method of monitoring the presence of a substance which comprises tagging the substance with a nucleic acid, collecting the substance and detecting said nucleic acid.
2. The method of claim 1 further comprising the step of amplifying nucleic acid.
3. The method of claim 2 wherein the step of amplifying is achieved using polymerase chain reaction technology.
4. The method of any of claims 1 to 3 wherein the nucleic acid is a synthetic nucleic acid.
5. The method of claim 4 wherein the nucleic acid comprises a derivatized nucleotide.
6. The method of any of claims 1 to 5 where the substance is selected from the group consisting of air pollutants, oils, aromatic compounds, explosive compositions, food stuffs, medicaments, inks, paper goods, and paint products.
7. A method of tagging a substance comprising the step of incorporating a nucleic acid having a specific sequence of nucleotide bases for retrospective identification into or onto the substance.
8. A composition comprising a nucleic acid having a specific sequence of nucleotide bases for retrospective identification and a substance selected from the group consisting of air pollutants, oils, aromatic compounds, explosive compositions, food stuffs, medicaments, inks, paper goods, and paint products.
9. A kit for the monitoring of substances comprising a nucleic acid taggant and a polynucleotide complementary to the taggant.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE69028402T DE69028402T2 (en) | 1989-05-22 | 1990-05-16 | METHOD FOR MARKING AND DETECTING SUBSTANCES WITH NUCLEIC ACIDS |
EP90908827A EP0477220B1 (en) | 1989-05-22 | 1990-05-16 | Methods for tagging and tracing materials with nucleic acids |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35544589A | 1989-05-22 | 1989-05-22 | |
US355,445 | 1989-05-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1990014441A1 true WO1990014441A1 (en) | 1990-11-29 |
Family
ID=23397459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1990/002709 WO1990014441A1 (en) | 1989-05-22 | 1990-05-16 | Methods for tagging and tracing materials with nucleic acids |
Country Status (10)
Country | Link |
---|---|
US (1) | US5451505A (en) |
EP (1) | EP0477220B1 (en) |
JP (1) | JP3082942B2 (en) |
AT (1) | ATE142274T1 (en) |
AU (1) | AU643217B2 (en) |
CA (1) | CA2017211C (en) |
DE (1) | DE69028402T2 (en) |
DK (1) | DK0477220T3 (en) |
ES (1) | ES2091243T3 (en) |
WO (1) | WO1990014441A1 (en) |
Cited By (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991017265A1 (en) * | 1990-05-04 | 1991-11-14 | James Howard Slater | An ultrasensitive microtrace procedure for monitoring the origin, movement and fate of any liquid or solid material |
WO1993015229A2 (en) * | 1992-02-04 | 1993-08-05 | E.I. Du Pont De Nemours And Company | Amplification of assay reporters by nucleic acid replication |
WO1994004918A1 (en) * | 1992-08-26 | 1994-03-03 | James Howard Slater | A method of marking a liquid |
WO1995002702A1 (en) * | 1993-07-12 | 1995-01-26 | James Howard Slater | A security device using an ultrasensitive microtrace for protecting materials, articles and items |
WO1995017670A1 (en) * | 1993-12-23 | 1995-06-29 | Gec-Marconi Limited | Labelling |
US5503805A (en) * | 1993-11-02 | 1996-04-02 | Affymax Technologies N.V. | Apparatus and method for parallel coupling reactions |
EP0714512A1 (en) * | 1993-08-20 | 1996-06-05 | Biocode, Inc. | Marking of products to establish identity and source |
WO1996017954A1 (en) * | 1994-12-08 | 1996-06-13 | Pabio | Chemical labelling of objects |
WO1996019586A1 (en) * | 1994-12-22 | 1996-06-27 | Visible Genetics Inc. | Method and composition for internal identification of samples |
EP0773227A1 (en) * | 1991-09-18 | 1997-05-14 | Affymax Technologies N.V. | Diverse collections of oligomers in use to prepare drugs, diagnostic reagents, pesticides or herbicides |
US5639603A (en) * | 1991-09-18 | 1997-06-17 | Affymax Technologies N.V. | Synthesizing and screening molecular diversity |
US5776713A (en) * | 1988-02-02 | 1998-07-07 | Biocode Ltd. | Marking of products to establish identity and source |
WO1998046544A1 (en) * | 1997-04-17 | 1998-10-22 | The Dow Chemical Company | Encapsulated vapor-detection and identification tags |
WO1998055648A1 (en) * | 1997-06-05 | 1998-12-10 | Chemtag As | Methods of labelling a material and of detecting such labelling |
WO1999013102A1 (en) * | 1997-09-05 | 1999-03-18 | november Aktiengesellschaft, Gesellschaft für Molekulare Medizin | Method for marking solid, liquid or gaseous substances |
WO1999042613A1 (en) * | 1998-02-20 | 1999-08-26 | Biotraces, Inc. | Methods and additives for microtagging fluids |
US5985548A (en) * | 1993-02-04 | 1999-11-16 | E. I. Du Pont De Nemours And Company | Amplification of assay reporters by nucleic acid replication |
WO2000039330A1 (en) * | 1998-12-23 | 2000-07-06 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Method for identifying the origin of organic liquids |
US6165778A (en) * | 1993-11-02 | 2000-12-26 | Affymax Technologies N.V. | Reaction vessel agitation apparatus |
WO2001007645A2 (en) * | 1999-07-22 | 2001-02-01 | november Aktiengesellschaft Gesellschaft für Molekulare Medizin | Method for marking solid, liquid and gaseous substances |
WO2002015158A1 (en) * | 2000-08-11 | 2002-02-21 | Starguard International Pty Ltd | Authentification method and device |
GB2342994B (en) * | 1998-10-20 | 2002-05-29 | Wrc Plc | Method of providing a detectable marker in a fluid |
EP1316618A2 (en) * | 2001-11-21 | 2003-06-04 | ID Technica Corporation | Nucleic acids for marking objects |
WO2004035831A1 (en) * | 2002-10-16 | 2004-04-29 | Bioneer Corporation | Method for identifying vehicle and oligonucleotide marker used therefor |
US6951687B2 (en) | 2002-06-21 | 2005-10-04 | Burntside Partners, Inc. | Multifunctional product markers and methods for making and using the same |
EP1717321A1 (en) * | 2005-04-29 | 2006-11-02 | Avvocato Alberto Franchi | System for surface identification of commercial products using DNA tracer |
US7163744B2 (en) | 2002-06-21 | 2007-01-16 | Burntside Partners, Inc. | Multi-functional product markers and methods for making and using the same |
WO2008033042A2 (en) * | 2006-09-12 | 2008-03-20 | Agresearch Limited | Method for identifying the origin of a compound biological product |
KR100851764B1 (en) * | 2001-06-27 | 2008-08-13 | (주)바이오니아 | Oligonucleotide marker which contains phase transfer catalyst and the material differentiating or discerning method which employs the same |
EP2012293A1 (en) * | 2007-07-06 | 2009-01-07 | Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO | Method for marking materials |
EP2298881A1 (en) * | 2008-05-21 | 2011-03-23 | NEC Soft, Ltd. | Nucleic acid molecule having the capacity to bond with a 2,4,6-trinitrophenyl structure, method for detecting compounds including a 2,4,6-trinitrophenyl structure using said nucleic acid molecule, and use of said nucleic acid molecule |
US8124333B2 (en) | 2003-04-16 | 2012-02-28 | APDN, Inc. | Methods for covalent linking of optical reporters |
WO2012030196A3 (en) * | 2010-09-03 | 2012-05-31 | Bioneer Corporation. | Oligonucleotide marker and method for identifying the same |
GB2489714A (en) * | 2011-04-05 | 2012-10-10 | Tracesa Ltd | Fluid identification system comprising encapsulated DNA |
US8372648B2 (en) | 2003-04-16 | 2013-02-12 | APDN (B.V.I.), Inc. | Optical reporter compositions |
US8415164B2 (en) | 2003-04-16 | 2013-04-09 | Apdn (B.V.I.) Inc. | System and method for secure document printing and detection |
US8415165B2 (en) | 2003-04-16 | 2013-04-09 | APDN (B.V.I.), Inc. | System and method for authenticating sports identification goods |
US8420400B2 (en) | 2003-04-16 | 2013-04-16 | APDN (B.V.I.), Inc. | System and method for authenticating tablets |
US8426216B2 (en) | 2003-04-16 | 2013-04-23 | APDN (B.V.I.), Inc. | Methods for authenticating articles with optical reporters |
US8669079B2 (en) | 2008-11-12 | 2014-03-11 | Cara Therapeutics, Inc. | Methods for genetic analysis of textiles made of Gossypium barbadense and Gossypium hirsutum cotton |
US8940485B2 (en) | 2008-11-12 | 2015-01-27 | Apdn (B.V.I.) Inc. | Methods for genotyping mature cotton fibers and textiles |
WO2015032836A1 (en) * | 2013-09-04 | 2015-03-12 | Maersk Olie Og Gas A/S | Enhanced hydrocarbon recovery |
US20150141264A1 (en) * | 2005-05-20 | 2015-05-21 | Apdn (B.V.I.) Inc. | In-field dna extraction, detection and authentication methods and systems therefor |
US9297032B2 (en) | 2012-10-10 | 2016-03-29 | Apdn (B.V.I.) Inc. | Use of perturbants to facilitate incorporation and recovery of taggants from polymerized coatings |
WO2017058936A1 (en) * | 2015-09-29 | 2017-04-06 | Kapa Biosystems, Inc. | High molecular weight dna sample tracking tags for next generation sequencing |
US9790538B2 (en) | 2013-03-07 | 2017-10-17 | Apdn (B.V.I.) Inc. | Alkaline activation for immobilization of DNA taggants |
WO2018014090A1 (en) * | 2016-07-22 | 2018-01-25 | Nucleotrace Pty. Ltd. | A method for amplification of nucleic acid sequences |
US9904734B2 (en) | 2013-10-07 | 2018-02-27 | Apdn (B.V.I.) Inc. | Multimode image and spectral reader |
US9919512B2 (en) | 2012-10-10 | 2018-03-20 | Apdn (B.V.I.) Inc. | DNA marking of previously undistinguished items for traceability |
US9963740B2 (en) | 2013-03-07 | 2018-05-08 | APDN (B.V.I.), Inc. | Method and device for marking articles |
US10047282B2 (en) | 2014-03-18 | 2018-08-14 | Apdn (B.V.I.) Inc. | Encrypted optical markers for security applications |
US10519605B2 (en) | 2016-04-11 | 2019-12-31 | APDN (B.V.I.), Inc. | Method of marking cellulosic products |
WO2020109432A1 (en) | 2018-11-27 | 2020-06-04 | Crime Solutions Limited | Security markers |
US10741034B2 (en) | 2006-05-19 | 2020-08-11 | Apdn (B.V.I.) Inc. | Security system and method of marking an inventory item and/or person in the vicinity |
US10745825B2 (en) | 2014-03-18 | 2020-08-18 | Apdn (B.V.I.) Inc. | Encrypted optical markers for security applications |
US10760182B2 (en) | 2014-12-16 | 2020-09-01 | Apdn (B.V.I.) Inc. | Method and device for marking fibrous materials |
US10920274B2 (en) | 2017-02-21 | 2021-02-16 | Apdn (B.V.I.) Inc. | Nucleic acid coated submicron particles for authentication |
US10995371B2 (en) | 2016-10-13 | 2021-05-04 | Apdn (B.V.I.) Inc. | Composition and method of DNA marking elastomeric material |
US11370984B2 (en) * | 2017-01-31 | 2022-06-28 | Forecast Technology Limited | Oil tagging |
Families Citing this family (103)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
US6083689A (en) * | 1990-10-16 | 2000-07-04 | Bayer Corporation | Sensitive immunoassays utilizing antibody conjugates with replicable DNA templates |
EP0834576B1 (en) | 1990-12-06 | 2002-01-16 | Affymetrix, Inc. (a Delaware Corporation) | Detection of nucleic acid sequences |
US6458530B1 (en) * | 1996-04-04 | 2002-10-01 | Affymetrix Inc. | Selecting tag nucleic acids |
US6110710A (en) * | 1996-10-15 | 2000-08-29 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Sequence modification of oligonucleotide primers to manipulate non-templated nucleotide addition |
AU717638B3 (en) * | 1999-01-18 | 2000-03-30 | Legends Genuine Memorabilia Pty Ltd | Product and method |
US6153389A (en) * | 1999-02-22 | 2000-11-28 | Haarer; Brian K. | DNA additives as a mechanism for unambiguously marking biological samples |
US6806478B1 (en) * | 1999-03-16 | 2004-10-19 | Cryovac, Inc. | Authentication system and methodology |
US20030207249A1 (en) * | 1999-04-15 | 2003-11-06 | Beske Oren E. | Connection of cells to substrates using association pairs |
US20030134330A1 (en) * | 1999-04-15 | 2003-07-17 | Ilya Ravkin | Chemical-library composition and method |
US20030129654A1 (en) * | 1999-04-15 | 2003-07-10 | Ilya Ravkin | Coded particles for multiplexed analysis of biological samples |
US7253435B2 (en) | 1999-04-15 | 2007-08-07 | Millipore Corporation | Particles with light-polarizing codes |
US6908737B2 (en) * | 1999-04-15 | 2005-06-21 | Vitra Bioscience, Inc. | Systems and methods of conducting multiplexed experiments |
WO2000063419A1 (en) * | 1999-04-15 | 2000-10-26 | Virtual Arrays, Inc. | Combinatorial chemical library supports having indicia at coding positions and methods of use |
US20030166015A1 (en) * | 1999-04-15 | 2003-09-04 | Zarowitz Michael A. | Multiplexed analysis of cell-substrate interactions |
US7112445B1 (en) * | 2000-05-19 | 2006-09-26 | Richard P Welle | Fragmented taggant coding system and method with application to ammunition tagging |
GB9927292D0 (en) | 1999-11-19 | 2000-01-12 | Maxwell Paul | Security system |
US7157564B1 (en) | 2000-04-06 | 2007-01-02 | Affymetrix, Inc. | Tag nucleic acids and probe arrays |
WO2003036265A2 (en) * | 2001-10-26 | 2003-05-01 | Virtual Arrays, Inc. | Assay systems with adjustable fluid communication |
US6560544B1 (en) * | 2000-04-28 | 2003-05-06 | Ford Motor Company | Method for monitoring a mixture |
JP2001352980A (en) * | 2000-06-07 | 2001-12-25 | Internatl Business Mach Corp <Ibm> | Method for describing information into dna, method for identifying source of genetic information, dna to which information is added, base sequence, and cell of organism |
DE10038169A1 (en) * | 2000-08-04 | 2002-03-07 | November Ag Molekulare Medizin | Synthetic particle for marking a substance |
US6629038B1 (en) * | 2000-09-05 | 2003-09-30 | Yeda Research And Development Co. Ltd. | Method and system for identifying commercially distributed organisms |
JP2004537712A (en) * | 2000-10-18 | 2004-12-16 | バーチャル・アレイズ・インコーポレーテッド | Multiple cell analysis system |
DE10055368A1 (en) * | 2000-11-08 | 2002-05-29 | Agrobiogen Gmbh Biotechnologie | Method for labeling samples containing DNA using oligonucleotides |
FR2819831A1 (en) * | 2001-01-22 | 2002-07-26 | Arjo Wiggins Sa | PAPER COMPRISING BODIES CARRYING AT LEAST ONE BIOCHEMICAL MARKER |
US7115301B2 (en) | 2001-04-09 | 2006-10-03 | Rixflex Holdings Limited | Method of marking solid or liquid substances with nucleic acid for anti-counterfeiting and authentication |
WO2002090581A2 (en) * | 2001-05-03 | 2002-11-14 | Genevision Inc. | A molecular tag code for monitoring a product and process using same |
GB0123278D0 (en) * | 2001-09-27 | 2001-11-21 | Ucb Sa | Labelled articles and uses thereof |
US20030219800A1 (en) * | 2001-10-18 | 2003-11-27 | Beske Oren E. | Multiplexed cell transfection using coded carriers |
US20080187949A1 (en) * | 2001-10-26 | 2008-08-07 | Millipore Corporation | Multiplexed assays of cell migration |
DE10222075A1 (en) * | 2002-05-17 | 2003-12-11 | Henkel Kgaa | Identification procedure for product protection |
US20040126773A1 (en) * | 2002-05-23 | 2004-07-01 | Beske Oren E. | Assays with coded sensor particles to sense assay conditions |
AR037006A1 (en) * | 2002-06-20 | 2004-10-20 | S I G Sist S De Identificacion | OBJECT MARKER TO IDENTIFY CONSISTENTLY AT LEAST A DNA FRAGMENT. |
DE10231435A1 (en) * | 2002-07-11 | 2004-02-12 | Sension, Biologische Detektions- Und Schnelltestsysteme Gmbh | Verification procedure for checking the originality of an object |
US20080073044A1 (en) * | 2002-08-13 | 2008-03-27 | Bowman David J | Apparatus for liquid-based fiber separation |
US7279073B2 (en) * | 2002-08-13 | 2007-10-09 | U.S. Greenfiber, Llc | Apparatus for liquid-based fiber separation |
WO2004016154A2 (en) * | 2002-08-16 | 2004-02-26 | John Wayne Cancer Institute | Molecular lymphatic mapping of sentinel lymph nodes |
US20040058457A1 (en) * | 2002-08-29 | 2004-03-25 | Xueying Huang | Functionalized nanoparticles |
US7361821B2 (en) * | 2002-09-20 | 2008-04-22 | Intel Corporation | Controlled alignment of nanobarcodes encoding specific information for scanning probe microscopy (SPM) reading |
CN1682237B (en) * | 2002-09-20 | 2010-05-26 | 英特尔公司 | Method and instrument for detecting biological molecule by coding probe |
US20080207465A1 (en) * | 2002-10-28 | 2008-08-28 | Millipore Corporation | Assay systems with adjustable fluid communication |
US20050112610A1 (en) * | 2003-04-16 | 2005-05-26 | Applied Dna Sciences, Inc. | System and method for marking textiles with nucleic acids |
US7820030B2 (en) | 2003-04-16 | 2010-10-26 | Handylab, Inc. | System and method for electrochemical detection of biological compounds |
JP2004329014A (en) * | 2003-04-30 | 2004-11-25 | Id Technica:Kk | Identification additive for adding identification means having function to prevent falsifying behavior and material holding identification information and method for detecting misuse of material holding identification information |
EP1676133A4 (en) * | 2003-09-15 | 2008-05-21 | Millipore Corp | Assays with primary cells |
US7488451B2 (en) * | 2003-09-15 | 2009-02-10 | Millipore Corporation | Systems for particle manipulation |
US20110059441A1 (en) * | 2007-04-16 | 2011-03-10 | Mcmaster University | Methof of producing bioactive paper |
GB2427685B (en) * | 2004-05-12 | 2009-01-07 | Axsun Tech Inc | Erasable taggant distribution channel validation method and system |
US20060073506A1 (en) | 2004-09-17 | 2006-04-06 | Affymetrix, Inc. | Methods for identifying biological samples |
JP4674796B2 (en) * | 2004-12-15 | 2011-04-20 | 日産自動車株式会社 | Non-exposed surface coating composition and non-exposed surface coating |
JP4674795B2 (en) * | 2004-12-15 | 2011-04-20 | 日産自動車株式会社 | Matte paint composition and matte paint film |
JP2006168084A (en) * | 2004-12-15 | 2006-06-29 | Nissan Motor Co Ltd | Laminated coating film structure |
JP4674793B2 (en) * | 2004-12-15 | 2011-04-20 | 日産自動車株式会社 | Undercoat paint composition and undercoat coating film |
JP4674794B2 (en) * | 2004-12-15 | 2011-04-20 | 日産自動車株式会社 | Clear coating composition and clear coating film |
JP2006169332A (en) * | 2004-12-15 | 2006-06-29 | Nissan Motor Co Ltd | Colored topcoat coating composition and colored topcoat coating film |
US7393665B2 (en) | 2005-02-10 | 2008-07-01 | Population Genetics Technologies Ltd | Methods and compositions for tagging and identifying polynucleotides |
US7874489B2 (en) * | 2005-06-20 | 2011-01-25 | Authentiform Technologies, Llc | Product authentication |
US8458475B2 (en) * | 2005-06-20 | 2013-06-04 | Authentiform Technologies, L.L.C. | Systems and methods for product authentication |
US8247018B2 (en) * | 2005-06-20 | 2012-08-21 | Authentiform Technologies, Llc | Methods for quality control |
US8785130B2 (en) * | 2005-07-07 | 2014-07-22 | Bio-Id Diagnostic Inc. | Use of markers including nucleotide sequence based codes to monitor methods of detection and identification of genetic material |
WO2007021971A2 (en) * | 2005-08-12 | 2007-02-22 | Pharmorx Inc. | Labeling compositions and methods of use for deterrent trackability |
WO2007034499A1 (en) * | 2005-09-26 | 2007-03-29 | Soreq Nuclear Research Center | Probe for tagging valuables based on dna-metal complex |
USH2257H1 (en) * | 2005-09-28 | 2011-06-07 | The United States Of America As Represented By The Secretary Of The Navy | Microtags for detection and identification of materials |
US20140106357A1 (en) * | 2012-10-16 | 2014-04-17 | Applied Dna Sciences, Inc. | Security system and method of marking an inventory item and/or person in the vicinity |
CH699631B1 (en) * | 2007-01-12 | 2010-04-15 | Suisse Electronique Microtech | Realizing a diffractive microstructure in a pill surface. |
US9592646B2 (en) * | 2006-06-13 | 2017-03-14 | Csem Centre Suisse D'electronique Et De Microtechnique Sa | Pharmaceutical tablets with diffractive microstructure and compression tools for producing such tablets |
DE102007026958B4 (en) * | 2006-06-13 | 2014-10-09 | Csem Centre Suisse D'electronique Et De Microtechnique S.A. | Press tool with diffractive microstructure and method for producing such a tool and tableting press |
DE102006044349A1 (en) * | 2006-09-18 | 2008-03-27 | Identif Gmbh | Local pre-authentication process for substance containing nucleic acid involves applying first liquid to surface of solid between stages |
ES2384941T3 (en) | 2007-02-16 | 2012-07-16 | Csem Centre Suisse D'electronique Et De Microtechnique Sa - Recherche Et Developpement | Verification method |
US20090008925A1 (en) * | 2007-05-07 | 2009-01-08 | Centre Suisse D'electronique Et De Microtechnique Sa | Security device for the identification or authentication of goods and method for securing goods using such a security device |
FR2930063B1 (en) * | 2008-04-14 | 2013-02-15 | Bioquanta | METHOD FOR MARKING A PRODUCT, METHOD FOR IDENTIFYING THE MARKING AND PRODUCT |
US20090269800A1 (en) * | 2008-04-29 | 2009-10-29 | Todd Covey | Device and method for processing cell samples |
US20100030719A1 (en) * | 2008-07-10 | 2010-02-04 | Covey Todd M | Methods and apparatus related to bioinformatics data analysis |
US9183237B2 (en) | 2008-07-10 | 2015-11-10 | Nodality, Inc. | Methods and apparatus related to gate boundaries within a data space |
GB2474613A (en) * | 2008-07-10 | 2011-04-20 | Nodality Inc | Methods and apparatus related to management of experiments |
US20100014741A1 (en) * | 2008-07-10 | 2010-01-21 | Banville Steven C | Methods and apparatus related to gate boundaries within a data space |
WO2010011833A1 (en) | 2008-07-23 | 2010-01-28 | Alexander Stuck | Secure tracking of tablets |
US9034257B2 (en) | 2008-10-27 | 2015-05-19 | Nodality, Inc. | High throughput flow cytometry system and method |
FR2942807B1 (en) * | 2009-03-09 | 2013-10-18 | Commissariat Energie Atomique | METHOD FOR DETECTING, IDENTIFYING AND / OR QUANTIFYING CARBON NANOTUBES |
US8053744B2 (en) * | 2009-04-13 | 2011-11-08 | Src, Inc. | Location analysis using nucleic acid-labeled tags |
GB2472371B (en) * | 2009-04-24 | 2011-10-26 | Selectamark Security Systems Plc | Synthetic nucleotide containing compositions for use in security marking of property and/or for marking a thief or attacker |
US9189728B2 (en) | 2009-07-23 | 2015-11-17 | I-Property Holding Corp. | Method for the authentication of dosage forms |
US8735327B2 (en) | 2010-01-07 | 2014-05-27 | Jeansee, Llc | Combinatorial DNA taggants and methods of preparation and use thereof |
US8703493B2 (en) | 2010-06-15 | 2014-04-22 | Src, Inc. | Location analysis using fire retardant-protected nucleic acid-labeled tags |
US8716027B2 (en) * | 2010-08-03 | 2014-05-06 | Src, Inc. | Nucleic acid-labeled tags associated with odorant |
KR101350919B1 (en) * | 2011-03-14 | 2014-01-14 | (주)바이오니아 | Method of Identifying Nucleic Acid-Containing Materials |
JP2013050941A (en) * | 2011-07-30 | 2013-03-14 | Visionbio Corp | Product inspection method |
US9057712B1 (en) | 2011-10-27 | 2015-06-16 | Copilot Ventures Fund Iii Llc | Methods of delivery of encapsulated perfluorocarbon taggants |
WO2014070958A1 (en) | 2012-10-30 | 2014-05-08 | Certirx Corporation | Product, image, or document authentication, verification, and item identification |
US9243283B2 (en) | 2012-11-19 | 2016-01-26 | Src, Inc. | System and method for authentication and tamper detection using nucleic acid taggants |
US9428792B2 (en) | 2013-03-14 | 2016-08-30 | Certirx Corporation | Nucleic acid-based authentication and identification codes |
CA3156663A1 (en) * | 2013-03-15 | 2014-09-18 | Verinata Health, Inc. | Generating cell-free dna libraries directly from blood |
US20140349861A1 (en) * | 2013-05-22 | 2014-11-27 | Sunpower Technologies Llc | Method for Distinguishing Biological Material Products |
US9751812B2 (en) | 2014-05-30 | 2017-09-05 | Elwha Llc | Taggant for cement authentication |
US20180016627A1 (en) * | 2015-03-17 | 2018-01-18 | Apdn (B.V.I.) Inc. | Method for authenticating active pharmaceutical ingredients |
EP3286333A4 (en) * | 2015-04-20 | 2018-11-21 | APDN (B.V.I.) Inc. | Hydrophobic nucleic acid salts as security markers |
US10047235B2 (en) * | 2015-12-08 | 2018-08-14 | Xerox Corporation | Encoding liquid ink with a device specific biomarker |
WO2017139403A1 (en) * | 2016-02-08 | 2017-08-17 | Apdn (B.V.I.) Inc. | Identifying marked articles in the international stream of commerce |
US20180194796A1 (en) * | 2017-01-12 | 2018-07-12 | Apdn (B.V.I.) Inc. | Traceable nucleic acid marked fertilizer |
WO2019204482A1 (en) * | 2018-04-17 | 2019-10-24 | Invisidex, Inc. | Composition of variegated witness mark |
US20230101083A1 (en) | 2021-09-30 | 2023-03-30 | Microsoft Technology Licensing, Llc | Anti-counterfeit tags using base ratios of polynucleotides |
US20230101409A1 (en) | 2021-09-30 | 2023-03-30 | Microsoft Technology Licensing, Llc | Anti-counterfeit tags using high-complexity polynucleotides |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4359353A (en) * | 1981-05-18 | 1982-11-16 | Hydrocarbon Research, Inc. | Polypeptides as chemical tagging materials |
US4441943A (en) * | 1981-05-18 | 1984-04-10 | Hri Inc. | Polypeptides as chemical tagging materials |
US4957858A (en) * | 1986-04-16 | 1990-09-18 | The Salk Instute For Biological Studies | Replicative RNA reporter systems |
US4786600A (en) * | 1984-05-25 | 1988-11-22 | The Trustees Of Columbia University In The City Of New York | Autocatalytic replication of recombinant RNA |
US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4683195A (en) * | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4703011A (en) * | 1985-11-12 | 1987-10-27 | Novagene, Inc. | Thymidine kinase deletion mutants of bovine herpesvirus-1 |
GB8529275D0 (en) * | 1985-11-28 | 1986-01-02 | Whitbread & Co Plc | Dna recombination |
JPH0684474B2 (en) * | 1986-02-26 | 1994-10-26 | 東レ・ダウコ−ニング・シリコ−ン株式会社 | Silica-containing organopolysiloxane composition |
GB8608629D0 (en) * | 1986-04-09 | 1986-05-14 | Biotechnica Ltd | Labelling |
ZA876216B (en) * | 1986-08-22 | 1989-04-26 | Cetus Corp | Purified thermostable enzyme |
CA1338457C (en) * | 1986-08-22 | 1996-07-16 | Henry A. Erlich | Purified thermostable enzyme |
EP0290144A1 (en) * | 1987-05-05 | 1988-11-09 | City of Hope | Method of detecting incipient resistance to therapeutic agents in cancer patients |
NO884048L (en) * | 1988-09-12 | 1990-03-13 | Cheminor As | ELECTROLYSE OF COPPER IN THIN SOLUTIONS CONTAINING LARGE AMOUNTS OF IRON. |
FR2649518B1 (en) * | 1989-07-07 | 1991-10-18 | Bioprobe Systems Sa | HIGH SECURITY ENCRYPTED MARKING METHOD AND DEVICE FOR THE PROTECTION OF VALUABLE OBJECTS |
-
1990
- 1990-05-16 DE DE69028402T patent/DE69028402T2/en not_active Expired - Lifetime
- 1990-05-16 WO PCT/US1990/002709 patent/WO1990014441A1/en active IP Right Grant
- 1990-05-16 AT AT90908827T patent/ATE142274T1/en not_active IP Right Cessation
- 1990-05-16 EP EP90908827A patent/EP0477220B1/en not_active Expired - Lifetime
- 1990-05-16 ES ES90908827T patent/ES2091243T3/en not_active Expired - Lifetime
- 1990-05-16 JP JP02508504A patent/JP3082942B2/en not_active Expired - Lifetime
- 1990-05-16 AU AU57419/90A patent/AU643217B2/en not_active Expired
- 1990-05-16 DK DK90908827.0T patent/DK0477220T3/en active
- 1990-05-18 CA CA002017211A patent/CA2017211C/en not_active Expired - Lifetime
-
1992
- 1992-05-21 US US07/887,424 patent/US5451505A/en not_active Expired - Lifetime
Non-Patent Citations (1)
Title |
---|
See references of EP0477220A1 * |
Cited By (103)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5776713A (en) * | 1988-02-02 | 1998-07-07 | Biocode Ltd. | Marking of products to establish identity and source |
AU663289B2 (en) * | 1990-05-04 | 1995-10-05 | Cypher Science Limited | An ultrasensitive microtrace procedure for monitoring the origin, movement and fate of any liquid or solid material |
GB2259363A (en) * | 1990-05-04 | 1993-03-10 | James Howard Slater | An ultrasensitive microtrace procedure for monitoring the origin, movement and fate of any liquid or solid material |
US5665538A (en) * | 1990-05-04 | 1997-09-09 | Slater; James Howard | Ultrasensitive microtrace procedure for monitoring the origin of a material |
GB2259363B (en) * | 1990-05-04 | 1994-05-04 | James Howard Slater | Monitoring the movement of material using DNA as microtrace additive |
WO1991017265A1 (en) * | 1990-05-04 | 1991-11-14 | James Howard Slater | An ultrasensitive microtrace procedure for monitoring the origin, movement and fate of any liquid or solid material |
US5639603A (en) * | 1991-09-18 | 1997-06-17 | Affymax Technologies N.V. | Synthesizing and screening molecular diversity |
EP0773227A1 (en) * | 1991-09-18 | 1997-05-14 | Affymax Technologies N.V. | Diverse collections of oligomers in use to prepare drugs, diagnostic reagents, pesticides or herbicides |
US6165717A (en) * | 1991-09-18 | 2000-12-26 | Affymax Technologies N.V. | Method of synthesizing diverse collections of oligomers |
US6143497A (en) * | 1991-09-18 | 2000-11-07 | Affymax Technologies N.V. | Method of synthesizing diverse collections of oligomers |
US6140493A (en) * | 1991-09-18 | 2000-10-31 | Affymax Technologies N.V. | Method of synthesizing diverse collections of oligomers |
US5770358A (en) * | 1991-09-18 | 1998-06-23 | Affymax Technologies N.V. | Tagged synthetic oligomer libraries |
US6416949B1 (en) | 1991-09-18 | 2002-07-09 | Affymax, Inc. | Method of synthesizing diverse collections of oligomers |
US5789162A (en) * | 1991-09-18 | 1998-08-04 | Affymax Technologies N.V. | Methods of synthesizing diverse collections of oligomers |
US5708153A (en) * | 1991-09-18 | 1998-01-13 | Affymax Technologies N.V. | Method of synthesizing diverse collections of tagged compounds |
WO1993015229A3 (en) * | 1992-02-04 | 1995-03-02 | Du Pont | Amplification of assay reporters by nucleic acid replication |
WO1993015229A2 (en) * | 1992-02-04 | 1993-08-05 | E.I. Du Pont De Nemours And Company | Amplification of assay reporters by nucleic acid replication |
US5643728A (en) * | 1992-08-26 | 1997-07-01 | Slater; James Howard | Method of marking a liquid |
WO1994004918A1 (en) * | 1992-08-26 | 1994-03-03 | James Howard Slater | A method of marking a liquid |
US5985548A (en) * | 1993-02-04 | 1999-11-16 | E. I. Du Pont De Nemours And Company | Amplification of assay reporters by nucleic acid replication |
WO1995002702A1 (en) * | 1993-07-12 | 1995-01-26 | James Howard Slater | A security device using an ultrasensitive microtrace for protecting materials, articles and items |
US5763176A (en) * | 1993-07-12 | 1998-06-09 | Slater; James Howard | Methods and devices for marking a solid and subsequently detecting the markings |
EP0714512A1 (en) * | 1993-08-20 | 1996-06-05 | Biocode, Inc. | Marking of products to establish identity and source |
EP0714512A4 (en) * | 1993-08-20 | 1997-08-20 | Biocode Inc | Marking of products to establish identity and source |
US5503805A (en) * | 1993-11-02 | 1996-04-02 | Affymax Technologies N.V. | Apparatus and method for parallel coupling reactions |
US5665975A (en) * | 1993-11-02 | 1997-09-09 | Affymax Technologies N.V. | Optical detectior including an optical alignment block and method |
US6165778A (en) * | 1993-11-02 | 2000-12-26 | Affymax Technologies N.V. | Reaction vessel agitation apparatus |
US6056926A (en) * | 1993-11-02 | 2000-05-02 | Affymax Technologies N.V. | Apparatus and method for parallel coupling reactions |
GB2286672A (en) * | 1993-12-23 | 1995-08-23 | Marconi Gec Ltd | Tagging substances or items |
WO1995017670A1 (en) * | 1993-12-23 | 1995-06-29 | Gec-Marconi Limited | Labelling |
WO1995017669A1 (en) * | 1993-12-23 | 1995-06-29 | Gec-Marconi Limited | Labelling |
WO1995017667A1 (en) * | 1993-12-23 | 1995-06-29 | Gec-Marconi Limited | Labelling |
FR2714474A1 (en) * | 1993-12-23 | 1995-06-30 | Marconi Gec Ltd | Method, composition and combination of enzymatic labeling, and test kit and corresponding labeled substance |
WO1996017954A1 (en) * | 1994-12-08 | 1996-06-13 | Pabio | Chemical labelling of objects |
GB2311370A (en) * | 1994-12-22 | 1997-09-24 | Visible Genetics Inc | Method and composition for the internal identification of samples |
GB2311370B (en) * | 1994-12-22 | 1998-12-02 | Visible Genetics Inc | Provision of internal identification to a sample comprising a target nucleic acid, prior to sequence analysis |
WO1996019586A1 (en) * | 1994-12-22 | 1996-06-27 | Visible Genetics Inc. | Method and composition for internal identification of samples |
US5776737A (en) * | 1994-12-22 | 1998-07-07 | Visible Genetics Inc. | Method and composition for internal identification of samples |
WO1998046544A1 (en) * | 1997-04-17 | 1998-10-22 | The Dow Chemical Company | Encapsulated vapor-detection and identification tags |
WO1998055648A1 (en) * | 1997-06-05 | 1998-12-10 | Chemtag As | Methods of labelling a material and of detecting such labelling |
WO1999013102A1 (en) * | 1997-09-05 | 1999-03-18 | november Aktiengesellschaft, Gesellschaft für Molekulare Medizin | Method for marking solid, liquid or gaseous substances |
WO1999042613A1 (en) * | 1998-02-20 | 1999-08-26 | Biotraces, Inc. | Methods and additives for microtagging fluids |
GB2342994B (en) * | 1998-10-20 | 2002-05-29 | Wrc Plc | Method of providing a detectable marker in a fluid |
US6528317B1 (en) | 1998-10-20 | 2003-03-04 | Wrc Plc | Method of providing a detectable marker in a fluid |
WO2000039330A1 (en) * | 1998-12-23 | 2000-07-06 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Method for identifying the origin of organic liquids |
WO2001007645A3 (en) * | 1999-07-22 | 2001-06-07 | November Ag Molekulare Medizin | Method for marking solid, liquid and gaseous substances |
WO2001007645A2 (en) * | 1999-07-22 | 2001-02-01 | november Aktiengesellschaft Gesellschaft für Molekulare Medizin | Method for marking solid, liquid and gaseous substances |
WO2002015158A1 (en) * | 2000-08-11 | 2002-02-21 | Starguard International Pty Ltd | Authentification method and device |
KR100851764B1 (en) * | 2001-06-27 | 2008-08-13 | (주)바이오니아 | Oligonucleotide marker which contains phase transfer catalyst and the material differentiating or discerning method which employs the same |
EP1316618A2 (en) * | 2001-11-21 | 2003-06-04 | ID Technica Corporation | Nucleic acids for marking objects |
EP1316618A3 (en) * | 2001-11-21 | 2003-12-10 | ID Technica Corporation | Nucleic acids for marking objects |
US6951687B2 (en) | 2002-06-21 | 2005-10-04 | Burntside Partners, Inc. | Multifunctional product markers and methods for making and using the same |
US7163744B2 (en) | 2002-06-21 | 2007-01-16 | Burntside Partners, Inc. | Multi-functional product markers and methods for making and using the same |
WO2004035831A1 (en) * | 2002-10-16 | 2004-04-29 | Bioneer Corporation | Method for identifying vehicle and oligonucleotide marker used therefor |
KR100851765B1 (en) * | 2002-10-16 | 2008-08-13 | (주)바이오니아 | Method for Identifying Car Using Oligonucleotides and Oligonucleotide Marker Used Therein |
US8420400B2 (en) | 2003-04-16 | 2013-04-16 | APDN (B.V.I.), Inc. | System and method for authenticating tablets |
US8372648B2 (en) | 2003-04-16 | 2013-02-12 | APDN (B.V.I.), Inc. | Optical reporter compositions |
US8415165B2 (en) | 2003-04-16 | 2013-04-09 | APDN (B.V.I.), Inc. | System and method for authenticating sports identification goods |
US8415164B2 (en) | 2003-04-16 | 2013-04-09 | Apdn (B.V.I.) Inc. | System and method for secure document printing and detection |
US9005985B2 (en) | 2003-04-16 | 2015-04-14 | Apdn (B.V.I.) Inc. | Optical reporter compositions |
US8426216B2 (en) | 2003-04-16 | 2013-04-23 | APDN (B.V.I.), Inc. | Methods for authenticating articles with optical reporters |
US8124333B2 (en) | 2003-04-16 | 2012-02-28 | APDN, Inc. | Methods for covalent linking of optical reporters |
EP1717321A1 (en) * | 2005-04-29 | 2006-11-02 | Avvocato Alberto Franchi | System for surface identification of commercial products using DNA tracer |
US20150141264A1 (en) * | 2005-05-20 | 2015-05-21 | Apdn (B.V.I.) Inc. | In-field dna extraction, detection and authentication methods and systems therefor |
US10741034B2 (en) | 2006-05-19 | 2020-08-11 | Apdn (B.V.I.) Inc. | Security system and method of marking an inventory item and/or person in the vicinity |
WO2008033042A3 (en) * | 2006-09-12 | 2008-07-17 | Agres Ltd | Method for identifying the origin of a compound biological product |
WO2008033042A2 (en) * | 2006-09-12 | 2008-03-20 | Agresearch Limited | Method for identifying the origin of a compound biological product |
EP2012293A1 (en) * | 2007-07-06 | 2009-01-07 | Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO | Method for marking materials |
US8431375B2 (en) | 2007-07-06 | 2013-04-30 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Method for marking materials |
WO2009008716A1 (en) * | 2007-07-06 | 2009-01-15 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Method for marking materials |
EP2298881A1 (en) * | 2008-05-21 | 2011-03-23 | NEC Soft, Ltd. | Nucleic acid molecule having the capacity to bond with a 2,4,6-trinitrophenyl structure, method for detecting compounds including a 2,4,6-trinitrophenyl structure using said nucleic acid molecule, and use of said nucleic acid molecule |
EP2298881A4 (en) * | 2008-05-21 | 2013-11-13 | Nec Software Ltd | Nucleic acid molecule having the capacity to bond with a 2,4,6-trinitrophenyl structure, method for detecting compounds including a 2,4,6-trinitrophenyl structure using said nucleic acid molecule, and use of said nucleic acid molecule |
US9290819B2 (en) | 2008-11-12 | 2016-03-22 | Apdn (B.V.I.) Inc. | Methods for genotyping mature cotton fibers and textiles |
US8669079B2 (en) | 2008-11-12 | 2014-03-11 | Cara Therapeutics, Inc. | Methods for genetic analysis of textiles made of Gossypium barbadense and Gossypium hirsutum cotton |
US8940485B2 (en) | 2008-11-12 | 2015-01-27 | Apdn (B.V.I.) Inc. | Methods for genotyping mature cotton fibers and textiles |
WO2012030196A3 (en) * | 2010-09-03 | 2012-05-31 | Bioneer Corporation. | Oligonucleotide marker and method for identifying the same |
GB2490207B (en) * | 2011-04-05 | 2014-11-26 | Tracesa Ltd | Fluid identification system comprising encapsulated DNA |
GB2489714B (en) * | 2011-04-05 | 2013-11-06 | Tracesa Ltd | Fluid Identification Method |
GB2490207A (en) * | 2011-04-05 | 2012-10-24 | Tracesa Ltd | Fluid identification system comprising encapsulated DNA |
WO2012136734A1 (en) | 2011-04-05 | 2012-10-11 | Tracesa Ltd. | Fluid identification system and production and use thereof |
US9322056B2 (en) | 2011-04-05 | 2016-04-26 | Tracesa, Ltd. | Fluid identification system and production and use thereof |
GB2489714A (en) * | 2011-04-05 | 2012-10-10 | Tracesa Ltd | Fluid identification system comprising encapsulated DNA |
US9926591B2 (en) | 2011-04-05 | 2018-03-27 | Tracesa, Ltd. | Fluid identification system and production and use thereof |
US9919512B2 (en) | 2012-10-10 | 2018-03-20 | Apdn (B.V.I.) Inc. | DNA marking of previously undistinguished items for traceability |
US9297032B2 (en) | 2012-10-10 | 2016-03-29 | Apdn (B.V.I.) Inc. | Use of perturbants to facilitate incorporation and recovery of taggants from polymerized coatings |
US9963740B2 (en) | 2013-03-07 | 2018-05-08 | APDN (B.V.I.), Inc. | Method and device for marking articles |
US9790538B2 (en) | 2013-03-07 | 2017-10-17 | Apdn (B.V.I.) Inc. | Alkaline activation for immobilization of DNA taggants |
WO2015032836A1 (en) * | 2013-09-04 | 2015-03-12 | Maersk Olie Og Gas A/S | Enhanced hydrocarbon recovery |
US10282480B2 (en) | 2013-10-07 | 2019-05-07 | Apdn (B.V.I) | Multimode image and spectral reader |
US9904734B2 (en) | 2013-10-07 | 2018-02-27 | Apdn (B.V.I.) Inc. | Multimode image and spectral reader |
US10047282B2 (en) | 2014-03-18 | 2018-08-14 | Apdn (B.V.I.) Inc. | Encrypted optical markers for security applications |
US10745825B2 (en) | 2014-03-18 | 2020-08-18 | Apdn (B.V.I.) Inc. | Encrypted optical markers for security applications |
US10760182B2 (en) | 2014-12-16 | 2020-09-01 | Apdn (B.V.I.) Inc. | Method and device for marking fibrous materials |
CN108138228A (en) * | 2015-09-29 | 2018-06-08 | 卡帕生物系统公司 | High-molecular-weight DNA sample for next generation's sequencing tracks label |
CN108138228B (en) * | 2015-09-29 | 2022-05-27 | 卡帕生物系统公司 | High molecular weight DNA sample tracking tag for next generation sequencing |
WO2017058936A1 (en) * | 2015-09-29 | 2017-04-06 | Kapa Biosystems, Inc. | High molecular weight dna sample tracking tags for next generation sequencing |
US11001834B2 (en) | 2015-09-29 | 2021-05-11 | Kapa Biosystems, Inc. | High-molecular weight DNA sample tracking tags for next generation sequencing |
US10519605B2 (en) | 2016-04-11 | 2019-12-31 | APDN (B.V.I.), Inc. | Method of marking cellulosic products |
WO2018014090A1 (en) * | 2016-07-22 | 2018-01-25 | Nucleotrace Pty. Ltd. | A method for amplification of nucleic acid sequences |
US10995371B2 (en) | 2016-10-13 | 2021-05-04 | Apdn (B.V.I.) Inc. | Composition and method of DNA marking elastomeric material |
US11370984B2 (en) * | 2017-01-31 | 2022-06-28 | Forecast Technology Limited | Oil tagging |
US10920274B2 (en) | 2017-02-21 | 2021-02-16 | Apdn (B.V.I.) Inc. | Nucleic acid coated submicron particles for authentication |
WO2020109432A1 (en) | 2018-11-27 | 2020-06-04 | Crime Solutions Limited | Security markers |
Also Published As
Publication number | Publication date |
---|---|
DE69028402T2 (en) | 1997-04-17 |
EP0477220A1 (en) | 1992-04-01 |
JPH04505708A (en) | 1992-10-08 |
ATE142274T1 (en) | 1996-09-15 |
ES2091243T3 (en) | 1996-11-01 |
AU5741990A (en) | 1990-12-18 |
JP3082942B2 (en) | 2000-09-04 |
CA2017211A1 (en) | 1990-11-22 |
US5451505A (en) | 1995-09-19 |
CA2017211C (en) | 2004-02-10 |
DE69028402D1 (en) | 1996-10-10 |
DK0477220T3 (en) | 1996-10-21 |
EP0477220B1 (en) | 1996-09-04 |
AU643217B2 (en) | 1993-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2017211C (en) | Methods for tagging and tracing materials with nucleic acids | |
EP0774012B1 (en) | A security device using an ultrasensitive microtrace for protecting materials, articles and items | |
US20160102215A1 (en) | Incorporating soluble security markers into cyanoacrylate solutions | |
CA2143339C (en) | A method of marking a liquid | |
AU2017223821B2 (en) | Methods and compositions for target detection | |
US5665538A (en) | Ultrasensitive microtrace procedure for monitoring the origin of a material | |
US20040166520A1 (en) | Identifying items with nucleic acid taggants | |
EP3222733A1 (en) | Polynucleotide capture materials, and methods of using same | |
US20120322669A1 (en) | Methods of marking materials | |
CA2311952A1 (en) | Fluorimetric detection system of a nucleic acid | |
WO2014152775A2 (en) | Nucleic acid-based authentication and identification codes | |
CN103154244A (en) | Oligonucleotide marker and method for identifying the same | |
US20110207125A1 (en) | Method for labelling a product using a plurality of polynucleotides, method for identifying the labelling and labelled product | |
AU738768B2 (en) | Methods of labelling a material and of detecting such labelling | |
JPH03123500A (en) | Fractionation of nucleic acid | |
US11473134B2 (en) | Method for the deconvolution of nucleic acid-containing substance mixtures | |
Boulet | Application of Capillary Electrophoresis Laser Induced Fluorescence to the Detection of Nucleic Acid Probe Fragments | |
US20130237450A1 (en) | Method for Detecting Nucleic Acids | |
JPH06113897A (en) | Method for measuring nucleic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE |
|
WR | Later publication of a revised version of an international search report | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1990908827 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1990908827 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1990908827 Country of ref document: EP |